ROR2 and neoplasm: Wnt5a/ROR2 signaling is associated with suppression of β-catenin/TCF-dependent transcriptional activity and down-regulated the expression of cyclin D1 in erythroleukemia cells [17], suggesting its anti-tumor role on cell proliferation.